# Top 50 Biotechnology Startup Investors in Switzerland in May 2026

## Zürcher Kantonal Bank
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 24
- Stages: Seed, Series A
- Focus: Health Care, Medical Device, Biotechnology

Zürcher Kantonalbank - as an independent, incorporated public-law institution - is wholly owned by the canton of Zurich.

## Foundation for Technological Innovation (FIT)
- Type: VC Fund
- Location: Lausanne, Vaud, Switzerland
- Relevant deals: 18
- Stages: Debt Financing, Grant, Seed
- Focus: Health Care, Biotechnology, Information Technology

The Foundation for Technological Innovation (FIT) has been helping startups since 1994, encourages entrepreneurship & supports innovation.

## BioMedPartners
- Type: VC Fund
- Location: Basel, Basel-Stadt, Switzerland
- Relevant deals: 18
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.

## VI Partners
- Type: VC Fund
- Location: Altendorf, Schwyz, Switzerland
- Relevant deals: 14
- Stages: Series A, Series C, Series B
- Focus: Health Care, Biotechnology, Medical Device

VI Partners are Venture Capitalists successfully financing outstanding teams and innovations in the Healthcare and Technology space since 20 years.

## Verve Ventures
- Type: VC Fund
- Location: Zug, Zug, Switzerland
- Relevant deals: 13
- Stages: Series A, Seed, Series B
- Focus: Health Care, Software, Biotechnology

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

## Eclosion SA
- Type: VC Fund
- Location: Geneva, Geneve, Switzerland
- Relevant deals: 11
- Stages: Seed, Series C
- Focus: Biotechnology, Pharmaceutical, Health Care

Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up

## Redalpine
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 9
- Stages: Series A, Seed, Series B
- Focus: Software, Biotechnology, Health Care

Redalpine is one of the leading European Venture Capital investors with a focus on highly scalable start-ups. The firm's mission is to help talented entrepreneurs turn an ambitious vision into reality by providing money, experience, coaching, and a strong network. The firm is focused on seed and early-stage investments in disruptivetechnologies in tech and health tech.
Redalpine launched its first fund (Redalpine Capital I) in 2007, following the founding partners’ track record of some excellent trade sales and IPOs as serial entrepreneurs and professional angel investors. In 2021 Redalpine closed its sixth fund (Redalpine Capital VI) and currently has approx. USD 1 Billion in AUM. The highly interdisciplinary Redalpine team supports more than 70 portfolio companies with operational and sector-specific expertise and with a rich international network.Redalpine started with its first fund (Redalpine Capital I) in 2007 based on the track-record of some excellent trade-sales and IPOs as serial entrepreneurs and professional angel investors. Redalpine sucessfully launched Redalpine Capital II in 2012 and Redalpine Capital III in 2016. The funds are registered in Luxemburg and backed by dozens of experienced entrepreneurs and investors representing various countries, and a broad range of industries.

## EQT life science
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 9
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.

## Schroder Adveq
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 9
- Stages: Series B, Series C, Series A
- Focus: Biotechnology, Health Care, Therapeutics

Schroders Capital provides investors with access to a broad range of private asset investment opportunities, portfolio building blocks and customised private asset strategies. With over $65 billion assets under management, we offer a diversified range of investment strategies, including real estate, private equity, secondaries, venture capital, infrastructure, securitised products and asset-based finance, insurance-linked securities and impact investing.  

## M Ventures
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 9
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

## Sofinnova Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 8
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

## GoBeyond
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 7
- Stages: Seed, Series A
- Focus: Information Technology, Medical, Software

GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.

## High-Tech Grunderfonds
- Type: VC Fund
- Location: Bonn, Nordrhein-Westfalen, Germany
- Relevant deals: 7
- Stages: Seed, Series A
- Focus: Software, Information Technology, Biotechnology

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

## Versant Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 7
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

## Novo Holdings
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 6
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

## Bernina BioInvest
- Type: VC Fund
- Location: Zug, Zug, Switzerland
- Relevant deals: 6
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Biopharma

Bernina BioInvest is an investment Firm.

## Novartis Venture Fund
- Type: VC Fund
- Location: Basel, Basel-Stadt, Switzerland
- Relevant deals: 6
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific

## Swisscom Ventures
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 5
- Stages: Series B, Series A
- Focus: Software, SaaS, Information Technology

Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007.Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technicalexpertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services.Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.

## Pureos Bioventures
- Type: VC Fund
- Location: Küsnacht, Zurich, Switzerland
- Relevant deals: 5
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Therapeutics, Health Care

Venture capital for companies developing innovative therapeutics.

## Kinled Holding
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 5
- Stages: Series A, Seed
- Focus: Health Care, Biotechnology, Software

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

## Index Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 5
- Stages: Series A, Series B, Seed
- Focus: Software, E-Commerce, Internet

Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.

## Fongit Seed Invest
- Type: VC Fund
- Location: Plan-les-ouates, Geneve, Switzerland
- Relevant deals: 4
- Stages: Seed, Series A, Series B
- Focus: Health Care, Medical, Biotechnology

Fongit Seed Invest (FSI) is the leading Seed Money Fund of Switzerland for young technology companies. It provides smart seed capital.

## Endeavour Vision
- Type: VC Fund
- Location: Geneva, Geneve, Switzerland
- Relevant deals: 4
- Stages: Series C, Series B, Series A
- Focus: Health Care, Medical, Biotechnology

Endeavour Vision is a venture capital and growth equity firm investing in transformative healthcare technologies.

## 4FO Ventures
- Type: VC Fund
- Location: Luxembourg, Luxembourg, Luxembourg
- Relevant deals: 4
- Stages: Series A, Seed, Series B
- Focus: Artificial Intelligence, Health Care, Medical

4FO Ventures

## Omega Funds
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 4
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

## New Enterprise Associates
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 4
- Stages: Series B, Series A, Series C
- Focus: Software, Health Care, Biotechnology

New Enterprise Associates, Inc. is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’slifecycle, from the seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.

## Neomed Management
- Type: VC Fund
- Location: Oslo, Oslo, Norway
- Relevant deals: 4
- Stages: Series B, Series C
- Focus: Health Care, Biotechnology, Medical

NeoMed Management is an international venture capital investment firm, exclusively focused on the healthcare industry. Founded in 1997, NeoMed has established five funds to date.NeoMed invests in emerging companies with outstanding growth prospects. These companies are developing innovative and proprietary medical products that addresssubstantial market opportunities in the pharmaceutical, medical device and diagnostics industries.NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has successfully invested in more than 30 companies in Europe, including Scandinavia, Switzerland, Germany and the UK, and in North America.From offices in Norway and Switzerland, NeoMed’s experienced investment team works closely with its entrepreneurs and a broader industry network to support the growth of its portfolio companies.NeoMed is currently focusing on NeoMed Innovation IV L.P. and NeoMed Innovation V L.P.

## Aargauische Kantonalbank
- Type: VC Fund
- Location: Aarau, Aargau, Switzerland
- Relevant deals: 4
- Stages: Series B, Series A, Seed
- Focus: Medical Device, Dental, Biotechnology

Aargauische Kantonalbank (AKB) is a classical universal bank for private and corporate clients and institutional investors. They offer comprehensive services in all areas of banking. Their strengths include the needs-based, personalized and comprehensive advice and a comprehensive and competent care. The AKB has 31 offices in the canton of Aargauand the adjacent area Solothurn Olten-Gösgen-Gäu. Their company has about 790 employees and about 79 students. They serve approximately 230,000 customers. The AKB has been awarded by the rating agency Standard & Poor's AA + rating.

## Aravis Ventures
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 4
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Aravis is the first independent Swiss on-shore private equity house, an established investor in the renewable energy and life science spaces. We are a "hands-on" investor taking leading positions and understanding the balance between finance, commercial assets and people. With this distinct and crafted approach, we are serving over 30leading investors including corporates, pension funds, government funds, insurance companies and family offices. Currently actively managing more than a quarter of a billion Swiss francs, we have a cumulative history of investments in over 100 companies. These have resulted in several noticeable exits including the divestment of several renewable energy companies and a number of life science reverse take-overs, listings and trade sales. Our many years of experience in the Swiss fund industry have enabled us to establish a platform with a comprehensive offering of investment, accounting, regulatory and reporting expertise. Located in Zurich, Aravis was founded in 2001.

## Penny Schiffer
- Type: Angel
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Health Care, Medical, Finance

Penny Schiffer - CEO & Co-founder @ Raized.ai

## Gilde Healthcare
- Type: VC Fund
- Location: Utrecht, Utrecht, The Netherlands
- Relevant deals: 4
- Stages: Series C, Series B, Series A
- Focus: Biotechnology, Health Care, Medical

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

## Initiative Capital Romandie
- Type: VC Fund
- Relevant deals: 3
- Stages: Series A, Series B, Series E
- Focus: Health Care, Biotechnology, Medical Device

Initiative Capital Romandie is a private equity fund that focuses on technology companies based in Western Switzerland.

## Inkef
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!

## Boehringer Ingelheim Venture Fund
- Type: VC Fund
- Location: Ingelheim Am Rhein, Rheinland-Pfalz, Germany
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

## Sunstone Life Science Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Series B, Series A
- Focus: Biotechnology, Health Care, Medical

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

## SICTIC
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Information Technology, Artificial Intelligence

How to Invest in Swiss Startups That Last The Investor community of the Swiss ICT Investor Club (SICTIC) helped to fund to more than 160 Swiss tech startups to date. While doing so, they learned a lot about what to watch out for and how to foster success. Read more Get your FREE angel handbook

## Inserm Transfert Initiative
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Medical, Health Care

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

## OrbiMed
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

## BB Biotech Ventures
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 3
- Stages: Series C, Series A
- Focus: Biotechnology, Health Care, Medical

BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernsey–based fund is advised by the Bellevue Asset Management Group, which has operations in Curaçao, Boston/USA and Kusnacht/Zurich, Switzerland. BB BIOTECH VENTURES has a dedicated teamof investment advisors and an advisory board. In addition, it is supported by all of the Group’s health care investment experts, and an extensive network of specialists and advisors. Our goal is to maximize the returns to our investors. To achieve this goal, we combine hard working, experience, networking, and focus on value creation.

## Aglaia BioMedical Ventures
- Type: VC Fund
- Location: Bilthoven, Utrecht, The Netherlands
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Therapeutics, Pharmaceutical

Aglaia is founded on the principle that the willingness to take risks on the very early stage ventures of today results in opportunities that may grow into the winning companies of tomorrow. As such, we are typically the first provider of capital for startup and early stage companies and a driving force behind product development. Since thenumber of technological discoveries in the biomedical field is growing fast, specialized knowledge regarding the translation of these discoveries into novel products is a prerequisite for success. Aglaia's focus on oncology is considered to be a differentiating asset. We invest in novel tools and technologies as well as components of contemporary drug development.Opportunities may be derived from research centers as well as from corporate spinouts. We select, develop and commercialize promising technologies up to a level where the technology becomes attractive to larger investors or pharmaceutical and biotech companies.

## BlueOcean Ventures
- Type: VC Fund
- Location: Plan-les-ouates, Geneve, Switzerland
- Relevant deals: 3
- Stages: Series A, Seed, Series B
- Focus: Health Care, Medical, Personal Health

BlueOcean Ventures SA provides capital, operational and company development advisory support (mentoring, company management, divestment experience, network, negotiation support) to entrepreneurs in Switzerland.
BlueOcean Ventures is based in Geneva, Switzerland.

## Polytech Ventures
- Type: VC Fund
- Location: Lausanne, Vaud, Switzerland
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Financial Services, FinTech, Software

Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world

## b2venture (formerly btov Partners)
- Type: VC Fund
- Location: Saint Gallen, Sankt Gallen, Switzerland
- Relevant deals: 3
- Stages: Series A, Seed, Series B
- Focus: Software, Health Care, Information Technology

Btov Partners is a venture capital firm focused on early-stage investments in digital and industrial technology companies. With investment teams in Digital and Industrial Tech, Btov invests EUR 50m per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.

## Wingman Ventures
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 3
- Stages: Pre-Seed, Seed, Series A
- Focus: Software, Artificial Intelligence, SaaS

We dedicate our know-how, experience and energy to the new generation of startup founders, helping them navigate the skies on their way to success.

## Pfizer Venture Investments
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Pfizer Venture Investments is a corporate venture capital firm that invests in areas of current or future strategic interest to Pfizer. It aims to remain at the forefront of life science advances. It identifies and invests in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’spipeline and shape the future of its industry.

## Broadview Ventures
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 3
- Stages: Series A, Seed, Debt Financing
- Focus: Health Care, Biotechnology, Medical Device

Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.

## EVA Basel
- Type: VC Fund
- Location: Basel, Basel-Stadt, Switzerland
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Biotechnology, Medical Device, Medical

EVA is sparring partner for new entrepreneurs in the Life Sciences with planned base in north-western SwitzerlandThey support start-ups by helping to bridge the gap between their business idea and the successful commercialization of their life sciences projects, innovations and technologies.They provide thorough coaching and activelyencourage contact with their wide-ranging network of experts and investors as well as providing seed-phase investments.In science and technology transfer, they act as the link between researchers, universities’ scientific liaison offices, potential investors and the market.

## TiVentures
- Type: VC Fund
- Location: Lugano, Ticino, Switzerland
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Analytics, Renewable Energy

TiVenture is a seed investment fund owned by the Fondazione Centenario Banca Stato that invests in early stage companies with innovative technologies and high growth potential, principally in southern Switzerland. TiVenture is actively looking and ready to support exceptional founders and entrepreneurs developing scalable products for the globalmarket. TiVenture has a diversified portfolio of companies and is mainly active in the life science, medical, high-tech and IT sectors.

## Baszucki Group
- Type: VC Fund
- Relevant deals: 2
- Stages: Seed
- Focus: Medical, Health Care, Biotechnology

Baszucki Group directs resources toward the greater good through mission-driven investments that improve human health, governance, and the health of our planet.

## NEST pension fund
- Type: VC Fund
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Health Care, Biotechnology, Medical

For more than 35 years, Nest, as the first ecological and ethical pension fund in Switzerland, has remained true to its guiding principle: the optimal provision for the companies affiliated with us and their employees.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co